These outcomes, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 aid the idea of targeting ACKR3 as a unique method to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Diseases. A exploration study published in Anesthesiology https://billp368roj7.worldblogged.com/profile